Researchers at Tel Aviv University's Gray Faculty of Medical & Health Sciences conducted a series of experiments using ...

Relacorilant/nab-paclitaxel significantly improved PFS and OS vs nab-paclitaxel alone in platinum-resistant ovarian cancer.

Research, headed by teams at Trinity College Dublin and University College Dublin, has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body ...

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body's immune response in advanced ovarian cancer.

"This work adds a critical piece to the puzzle of why ovarian cancer is so aggressive and has such poor outcomes. While the immune system is naturally equipped to detect and destroy cancer cells ...

In particular, natural killer cells, are emerging as an optimal cell target for immunotherapy in ovarian cancer. Natural killer cells are a type of white blood cell responsible for eliminating ...

The paper is titled "Adaptive NK Cells Exhibit Tumour-Specific Immune Memory and Cytotoxicity in Ovarian Cancer." Adaptive NK cells, aNK cells, are a subset of NK cells that can remember past ...

"Our results demonstrate that aNK cells have great potential for treating cancer, especially for patients with difficult-to-treat ovarian cancer," says Dhifaf Sarhan, senior lecturer at the ...

"Our results demonstrate that aNK cells have great potential for treating cancer, especially for patients with difficult-to-treat ovarian cancer," says Dhifaf Sarhan, senior lecturer at the ...

and delivers a TOP1 inhibitor directly to cancer cells, according to a press release, which went on to note that in the phase 2 RAINFOL-01 clinical trial, Rina-S demonstrated antitumor activity in ...